相关实验视频

Updated: Jun 20, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

在固体瘤治疗中,CAR-T细胞疗法针对美索林的应用

Qiuhong Chen¹, Yang Sun¹, Hua Li²

¹Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, No. 88 East Wenhua Road, Jinan, 250014, People's Republic of China.

Discover oncology

|July 18, 2024

概括

化学抗原受体 (CAR) -T细胞疗法通过向美索林 (MSLN) 显示出对固体瘤的希望. 正在制定战略以优化MSLN-CAR-T细胞并提高其抗瘤功效,以改善癌症治疗结果.

科学领域:

免疫治疗是一种免疫疗法.
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体 (CAR) -T细胞疗法对血液癌症非常有效.
固体瘤存在独特的挑战,包括瘤微环境 (TME),毒性和贩运问题,用于CAR-T治疗.
梅索他林 (MSLN) 是CAR-T治疗的有希望的标,因为它在各种固体瘤上表达.

研究的目的:

审查CAR-T细胞治疗固体瘤的发展情况.
探索优化针对MSLN的CAR-T细胞的策略.
要总结提高MSLN-CAR-T细胞抗瘤功效的方法.

主要方法:

关于临床前实验和临床试验的文献综述.
对CAR-T细胞疗法发展和MSLN结构特征的分析.
对结构优化和效率增强策略的研究综合.

主要成果:

在固体瘤中,MSLN是CAR-T治疗的合适标.
为了优化MSLN-CAR-T细胞结构和功能,存在各种策略.
临床前和临床数据支持针对MSLN的CAR-T细胞的潜力.

结论:

针对MSLN的CAR-T细胞治疗是一种正在发展中的固体瘤治疗方法.
优化CAR-T细胞设计和克服TME挑战对于疗效至关重要.
这次审查整合了研究,以提出对固体瘤的可行治疗计划.

关键词:

在CAR-T细胞疗法中.梅索他林是其中一种蛋白质.固体瘤是一种固体瘤.

更多相关视频

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...